PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35019766-3	2022	Ceftazidime-avibactam (CZA) has shown good efficacy against large portions of KPC-2-producing CRPA strains.	avibactam, ceftazidime drug combination	0-21	KPC-2	Pseudomonas aeruginosa	78-83	
34726488-7	2021	blaKPC-2 plasmid curing in 28 strains restored CAZ-AVI susceptibility, suggesting that blaKPC-2 was the mediator of CAZ-AVI resistance.	avibactam, ceftazidime drug combination	47-54	KPC-2	Pseudomonas aeruginosa	87-95	
34726488-7	2021	blaKPC-2 plasmid curing in 28 strains restored CAZ-AVI susceptibility, suggesting that blaKPC-2 was the mediator of CAZ-AVI resistance.	avibactam, ceftazidime drug combination	116-123	KPC-2	Pseudomonas aeruginosa	87-95	
34726488-8	2021	Furthermore, the blaKPC-2 copy number was found to correlate with KPC expression and, therefore, CAZ-AVI resistance.	avibactam, ceftazidime drug combination	97-104	KPC-2	Pseudomonas aeruginosa	17-25	
35019766-3	2022	Ceftazidime-avibactam (CZA) has shown good efficacy against large portions of KPC-2-producing CRPA strains.	avibactam, ceftazidime drug combination	23-26	KPC-2	Pseudomonas aeruginosa	78-83